{"transactions":[{"id":695503,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-05T21:27:13.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest 50% of the total on each of the first and second anniversaries of the vesting commencement date, in each case subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed."}],"balance_after":15000,"derivative":{"exercise_price":1.12,"expiration_date":"2036-08-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001745566-26-000010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174556626000010/ownership.xml","form_type":"4"}},{"id":751448,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-06-04T00:51:22.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":27,"price":1.3,"value":35.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":868,"source":{"system":"sec-edgar","filing":"0001745566-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174556626000006/ownership.xml","form_type":"4"}},{"id":896546,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-02-18T21:26:55.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":20,"price":1.1,"value":22.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 20 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":895,"source":{"system":"sec-edgar","filing":"0001745566-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174556626000004/ownership.xml","form_type":"4"}},{"id":919268,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T21:17:32.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":27737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date."}],"balance_after":27737,"derivative":{"exercise_price":1.27,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":27737},"source":{"system":"sec-edgar","filing":"0001745566-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174556626000002/ownership.xml","form_type":"4"}},{"id":1041367,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-12T21:02:22.000Z","date":"2025-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":59,"price":4.06,"value":239.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":915,"source":{"system":"sec-edgar","filing":"0001745566-25-000007","document":"wk-form4a_1757710939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174556625000007/wk-form4a_1757710939.xml","form_type":"4/A","original_submission_date":"2025-09-12"}},{"id":1041368,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-12T20:49:30.000Z","date":"2025-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":59,"price":4.06,"value":239.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":915,"source":{"system":"sec-edgar","filing":"0001745566-25-000005","document":"wk-form4_1757710167.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174556625000005/wk-form4_1757710167.xml","form_type":"4"}},{"id":1124673,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-06-03T22:59:01.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":27,"price":3.69,"value":99.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":974,"source":{"system":"sec-edgar","filing":"0001411690-25-000056","document":"wk-form4_1748991535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000056/wk-form4_1748991535.xml","form_type":"4"}},{"id":1199461,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T22:45:26.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":6966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date."}],"balance_after":6966,"derivative":{"exercise_price":3.47,"expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":6966},"source":{"system":"sec-edgar","filing":"0001411690-25-000027","document":"wk-form4_1742337920.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000027/wk-form4_1742337920.xml","form_type":"4"}},{"id":1259591,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-02-19T23:57:21.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":20,"price":5.73,"value":114.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 20 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 20 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 60,262 less shares of common stock."}],"balance_after":1001,"source":{"system":"sec-edgar","filing":"0001411690-25-000019","document":"wk-form4_1740009430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000019/wk-form4_1740009430.xml","form_type":"4"}},{"id":1407580,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-09-13T20:15:18.000Z","date":"2024-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":3568,"price":0.48,"value":1712.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 3,568 shares of common stock that vested on September 11, 2024, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 3,568 shares of common stock that vested on September 11, 2024, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 153 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024."}],"balance_after":61283,"source":{"system":"sec-edgar","filing":"0001411690-24-000053","document":"wk-form4_1726258505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169024000053/wk-form4_1726258505.xml","form_type":"4"}},{"id":1489808,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:49:36.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":75000,"derivative":{"exercise_price":0.93,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-24-015624","document":"form4-06052024_090633.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015624/form4-06052024_090633.xml","form_type":"4"}},{"id":1489807,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-06-05T21:49:36.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 54 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 9, 2023."}],"balance_after":64698,"source":{"system":"sec-edgar","filing":"0001415889-24-015624","document":"form4-06052024_090633.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015624/form4-06052024_090633.xml","form_type":"4"}},{"id":1595277,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-03-05T22:47:34.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1229,"price":1.27,"value":1560.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 1,229 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 1,229 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 268,058 less shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023."}],"balance_after":48644,"source":{"system":"sec-edgar","filing":"0001415889-24-006810","document":"form4-03052024_100327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924006810/form4-03052024_100327.xml","form_type":"4"}},{"id":1776109,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-20T21:38:40.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of September 11, 2023 (the \"Vesting Commencement Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Vesting Commencement Date."}],"balance_after":40000,"derivative":{"exercise_price":3,"expiration_date":"2033-09-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-050186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123050186/doc4.xml","form_type":"4"}},{"id":1776108,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-09-20T21:38:40.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."}],"balance_after":317842,"source":{"system":"sec-edgar","filing":"0001209191-23-050186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123050186/doc4.xml","form_type":"4"}},{"id":1891346,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-05-16T22:20:04.000Z","date":"2023-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":41496,"price":0.66,"value":27387.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 41,496 shares of common stock that vested on May 12, 2023 pursuant to an RSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":297842,"source":{"system":"sec-edgar","filing":"0001411690-23-000030","document":"wf-form4_168427559071904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000030/wf-form4_168427559071904.xml","form_type":"4"}},{"id":2007299,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-18T00:22:56.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":560000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":560000,"derivative":{"exercise_price":1.63,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":560000},"source":{"system":"sec-edgar","filing":"0001209191-23-010920","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123010920/doc4.xml","form_type":"4"}},{"id":2007298,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-02-18T00:22:56.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,424 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 10, 2022 and 1,245 shares acquired under the ESPP on December 10, 2022."}],"balance_after":339338,"source":{"system":"sec-edgar","filing":"0001209191-23-010920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123010920/doc4.xml","form_type":"4"}},{"id":2270170,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-05-17T01:27:45.000Z","date":"2022-05-12","kind":"tax_withholding","acquired":false,"shares":41496,"price":1.41,"value":58509.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 41,496 shares of common stock that vested on May 12, 2022 pursuant to an RSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,139 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 10, 2021 and 2,940 shares acquired under the ESPP on December 10, 2021."}],"balance_after":216669,"source":{"system":"sec-edgar","filing":"0001209191-22-029458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919122029458/doc4.xml","form_type":"4"}},{"id":2394250,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-16T02:06:52.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":650000,"derivative":{"exercise_price":2.18,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001209191-22-010048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919122010048/doc4.xml","form_type":"4"}},{"id":2712199,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-05-14T23:15:30.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: 495 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on December 10, 2018, 1,021 shares acquired under the ESPP on June 10, 2019, 1,405 shares acquired under the ESPP on December 10, 2019, 1,199 shares acquired under the ESPP on June 10, 2020 and 1,151 shares acquired under the ESPP on December 10, 2020."}],"balance_after":252086,"source":{"system":"sec-edgar","filing":"0001209191-21-032932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121032932/doc4.xml","form_type":"4"}},{"id":2760906,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T22:31:21.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of April 1, 2021 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":275000,"derivative":{"exercise_price":7.83,"expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001209191-21-024788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121024788/doc4.xml","form_type":"4"}},{"id":3222459,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-06T19:07:30.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of March 1, 2019 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":60000,"derivative":{"exercise_price":4.25,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-016871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919120016871/doc4.xml","form_type":"4"}},{"id":3259233,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"Borodkin Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-21T00:24:28.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 18, 2020 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":120000,"derivative":{"exercise_price":1.04,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-20-011298","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919120011298/doc4.xml","form_type":"4"}},{"id":3690565,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"Borodkin Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-23T02:08:45.000Z","date":"2019-01-18","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vested on February 7, 2017, and the remaining shares vest in 12 equal quarterly installments thereafter."}],"balance_after":28219,"derivative":{"exercise_price":1.3,"expiration_date":"2027-02-06","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-19-004894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919119004894/doc4.xml","form_type":"4"}},{"id":3690564,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"Borodkin Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-23T02:08:45.000Z","date":"2019-01-18","kind":"exercise","acquired":true,"shares":6000,"price":1.3,"value":7800.0,"ownership":{"direct":true},"balance_after":6815,"source":{"system":"sec-edgar","filing":"0001209191-19-004894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919119004894/doc4.xml","form_type":"4"}},{"id":3798454,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"Borodkin Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-03T20:48:11.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":59590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on October 1, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":59590,"derivative":{"exercise_price":7.77,"expiration_date":"2028-09-30","underlying":"Common Stock","underlying_shares":59590},"source":{"system":"sec-edgar","filing":"0001209191-18-053866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118053866/doc4.xml","form_type":"4"}},{"id":3832711,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"Borodkin Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock Warrants (right to buy)","published_at":"2018-08-27T22:52:58.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":815,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Units purchased in the Issuer's Initial Public Offering for $6.125 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"9/21/18 or such earlier date as Roth Capital Partners LLC, as representative of the underwriters in the Company's Initial Public Offering, shall determine."}],"balance_after":815,"derivative":{"exercise_price":6.125,"expiration_date":"2023-08-21","underlying":"Common Stock","underlying_shares":815},"source":{"system":"sec-edgar","filing":"0001209191-18-048558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118048558/doc4.xml","form_type":"4"}},{"id":3832710,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"Borodkin Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-08-27T22:52:58.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":815,"price":6.125,"value":4991.875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Units purchased in the Issuer's Initial Public Offering for $6.125 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock."}],"balance_after":815,"source":{"system":"sec-edgar","filing":"0001209191-18-048558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118048558/doc4.xml","form_type":"4"}}]}